Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer
Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
Adding ultrasound to routine mammography improves cancer detection in dense breasts
CLL at ASH 2014: Expert discussion
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
Best of ASH 2014
ASH 2014: Highlights in CLL from ASH 2014
Hope for avoiding chemo in patients with Hodgkins lymphoma
ASH 2014: Highlights in mantle cell lymphoma
Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults